Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)
European Journal of Cancer · 2026-12 · 249 · 117791
DOI: 10.1016/j.ejca.2026.117791 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Rachel Galot und 20 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Univers…. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Boehringer Ingelheim GmbH, Pfizer Inc, GSK plc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 10, Brussels…
- Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research unit, Saint-Cloud, France; Paris-Saclay University, Paris, France. Electronic address: christophe.letourne…
- Head and Neck Cancer Medical Oncology Department, Fondazione IRCCS "Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Department of Oncology and Hemato-oncology, Italy. Electronic address: lisa.licitra@i…
- Department of Medical Oncology, Centre Antoine Lacassagne, 33 avenue de Valombrose, Nice cedex 2 06189, France; Laboratory of Translational Research in Oncology, Cote d'Azur University, Nice, France. Electronic address:…
- Comprehensive Cancer Centre, King's College London, Guy's Campus, New Hunt's House, London SE1 1UL, United Kingdom. Electronic address: anthony.kong@kcl.ac.uk.
- Department of Radiooncology and Radiotherapy, Charite - Universitaetsmedizin Berlin - Campus Mitte, Berlin, Germany. Electronic address: ingeborg.tinhofer@charite.de.
Förderung
- Boehringer Ingelheim GmbH
- Pfizer Inc
- GSK plc
Zitieren
APA
Galot, R., Le Tourneau, C., Licitra, L., Guigay, J., Kong, A., Tinhofer, I., Even, C., Daste, A., Saada-Bouzid, E., Rolland, F., Henry, S., Rottey, S., Seront, E., Rutten, A., van der Elst, A., Tsechilidou, K., Dirix, L., Fortpied, C., Joaquim, A., …, & Machiels, J. P. (2026). Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM). European Journal of Cancer, 249, 117791. https://doi.org/10.1016/j.ejca.2026.117791
Vancouver
Galot R, Le Tourneau C, Licitra L, Guigay J, Kong A, Tinhofer I, et al. Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM). European Journal of Cancer. 2026;249:117791. doi:10.1016/j.ejca.2026.117791
BibTeX
@article{Galot2026,
author = {Galot, Rachel and Le Tourneau, Christophe and Licitra, Lisa and Guigay, Joël and Kong, Anthony and Tinhofer, Ingeborg and Even, Caroline and Daste, Amaury and Saada-Bouzid, Esma and Rolland, Frédéric and Henry, Stéphanie and Rottey, Sylvie and Seront, Emmanuel and Rutten, Annemie and van der Elst, Athénais and Tsechilidou, Konstantina and Dirix, Lieve and Fortpied, Catherine and Joaquim, Ana and Govaerts, Anne-Sophie and Machiels, Jean-Pascal},
title = {Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)},
journal = {European Journal of Cancer},
year = {2026},
volume = {249},
pages = {117791},
doi = {10.1016/j.ejca.2026.117791}
}
EUVIMED